Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants

Psychopharmacology

Volumn 217, Issue 1, 2011, Pages 101-110

  Simmons, Julian G ^a,b   Nathan, Pradeep J ^c,d   Berger, Gregor ^a,e   Allen, Nicholas B ^a  

^a THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e Department of Adolescent Psychiatry   (Switzerland)

Author keywords

Adult; Antidepressants; Healthy; LDAEP; Serotonin; Sertraline; SSRI

Indexed keywords

PLACEBO; SEROTONIN; SEROTONIN TRANSPORTER; SERTRALINE;

ADULT; ARTICLE; CAUCASIAN; CHINESE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; ETHNICITY; EVOKED AUDITORY RESPONSE; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HORMONE ACTION; HUMAN; HUMAN EXPERIMENT; INDIAN; LOUDNESS; MALE; NEUROTRANSMISSION; NORMAL HUMAN; PLACEBO EFFECT; PRIMARY AUDITORY CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTONINERGIC SYSTEM;

ADULT; BIOLOGICAL AVAILABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; GENOTYPE; HUMANS; LOUDNESS PERCEPTION; MALE; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SYNAPTIC TRANSMISSION; TIME FACTORS; YOUNG ADULT;

EID: 82955198470     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2265-9     Document Type: Article

References (92)

1. AARP Bulletin Today. (2009) The 50 most prescribed drugs. From http://assets.aarp.org/www.aarp.org-/articles/bulletin/interactive/powerof50/ oct09/index.html. Accessed 10 November 2010
2. Anderson GM, Bennett AJ, Weld KP, Pushkas JG, Ocame DM, Higley JD (2002) Serotonin in cisternal cerebrospinal fluid of rhesus monkeys: basal levels and effects of sertraline administration. Psychopharmacology (Berl) 161(1):95-99 (Pubitemid 34437974)
3. Arce E, Simmons AN, Lovero KL, Stein MB, Paulus MP (2008) Escitalopram effects on insula and amygdala BOLD activation during emotional processing. Psychopharmacology (Berl) 196 (4):661-672
4. Aznavour N, Rbah L, Riad M, Reilhac A, Costes N, Descarries L et al (2006) A PET imaging study of 5-HT(1A) receptors in cat brain after acute and chronic fluoxetine treatment. Neuroimage 33 (3):834-842 (Pubitemid 44584760)
5. Beck AT, Steer RA (1987) Beck depression inventory manual. HBJ, San Antonio
6. Benedetti F, Colombo C, Serretti A, Lorenzi C, Pontiggia A, Barbini B et al (2003) Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene. Biol Psychiatry 54(7):687-692 (Pubitemid 37281384)
7. Beyer CE, Cremers TI (2008) Do selective serotonin reuptake inhibitors acutely increase frontal cortex levels of serotonin? Eur J Pharmacol 580(3):350-354
8. Brett MA, Dierdorf HD, Zussman BD, Coates PE (1987) Determination of paroxetine in human plasma, using high-performance liquid chromatography with fluorescence detection. J Chromatography 419:438-444 (Pubitemid 17141423)
9. Brocke B, Beauducel A, John R, Debener S, Heilemann H (2000) Sensation seeking and affective disorders: characteristics in the intensity dependence of acoustic evoked potentials. Neuropsychobiology 41(1):24-30 (Pubitemid 30025908)
10. Burghardt NS, Sullivan GM, McEwen BS, Gorman JM, LeDoux JE (2004) The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 55 (12):1171-1178 (Pubitemid 38739451)
11. Carrillo-de-la-Pena MT (2001) One-year test-retest reliability of auditory evoked potentials (AEPs) to tones of increasing intensity. Psychophysiology 38(3):417-424 (Pubitemid 32422285)
12. Carver CS, Miller CJ (2006) Relations of serotonin function to personality: current views and a key methodological issue. Psychiatry Res 144(1):1-15 (Pubitemid 44332540)
13. Chen TJ, Yu YW, Chen MC, Tsai SJ, Hong CJ (2002) Association analysis for serotonin transporter promoter polymorphism and auditory evoked potentials for major depression. Neuropsychobiology 46 (2):57-60 (Pubitemid 36151304)
14. Connolly JF, Gruzelier JH (1982) Amplitude and latency changes in the visual evoked potential to different stimulus intensities. Psychophysiology 19(6):599-608 (Pubitemid 13247348)
15. Cook EW, III. (2000) VPM reference manual (version 11.2). University of Alabama, Birmingham
16. Croft RJ, Klugman A, Baldeweg T, Gruzelier JH (2001) Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users. Am J Psychiatry 158(10):1687-1692 (Pubitemid 32923663)
17. Debener S, Strobel A, Kurschner K, Kranczioch C, Hebenstreit J, Maercker A et al (2002) Is auditory evoked potential augmenting/ reducing affected by acute tryptophan depletion? Biol Psychol 59 (2):121-133 (Pubitemid 34242636)
18. Deecher D, Andree TH, Sloan D, Schechter LE (2008) From menarche to menopause: exploring the underlying biology of depression in women experiencing hormonal changes. Psychoneuroendocrinology 33(1):3-17
19. Derogatis L (1977) SCL-90-R version: manual I. John Hopkins University Press, Baltimore
20. Doogan DP (1991) Toleration and safety of sertraline: experience worldwide. Int Clin Psychopharmacol 6(Suppl 2):47-56
21. Eichhammer P, Langguth B, Wiegand R, Kharraz A, Frick U, Hajak G (2003) Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI). Psychopharmacology (Berl) 166(3):294-297 (Pubitemid 36384777)
22. First MB, Spitzer RL, Gibbon M, Williams JBW (1994) Structured clinical interview for Axis I DSM-IV disorders. New York State Psychiatric Institute, New York
23. Fitzgerald PB, Mellow TB, Hoy KE, Segrave R, Cooper NR, Upton DJ et al (2009) A study of intensity dependence of the auditory evoked potential (IDAEP) in medicated melancholic and nonmelancholic depression. J Affect Disord 117(3):212-216
24. Furlan PM, Kallan MJ, Have TT, Lucki I, Katz I (2004) SSRIs do not cause affective blunting in healthy elderly volunteers. Am J Geriatr Psychiatry 12(3):323-330 (Pubitemid 38569161)
25. Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ et al (2000) The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology (Berlin) 148(4):404-411 (Pubitemid 30169759)
26. Gallinat J, Senkowski D, Wernicke C, Juckel G, Becker I, Sander T et al (2003) Allelic variants of the functional promoter polymor- phism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacology 28(3):530-532
27. Gelernter J, Kranzler H, Cubells JF (1997) Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects. Hum Genet 101 (2):243-246 (Pubitemid 28014742)
28. Gelernter J, Kranzler H, Coccaro EF, Siever LJ, New AS (1998) Serotonin transporter protein gene polymorphism and personality measures in African American and European American subjects. Am J Psychiatry 155(10):1332-1338 (Pubitemid 28471188)
29. Gelernter J, Cubells JF, Kidd JR, Pakstis AJ, Kidd KK (1999) Population studies of polymorphisms of the serotonin transporter protein gene. Am J Med Genet 88(1):61-66 (Pubitemid 29075323)
30. Gressier F, Bouaziz E, Verstuyft C, Hardy P, Becquemont L, Corruble E (2009) 5-HTTLPR modulates antidepressant efficacy in depressed women. Psychiatr Genet 19(4):195-200
31. Gudlowski Y, Ozgurdal S, Witthaus H, Gallinat J, Hauser M, Winter C et al (2009) Serotonergic dysfunction in the prodromal, firstepisode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity. Schizophr Res 109(1-3):141-147
32. Guille V, Croft RJ, O'Neill BV, Illic S, Phan KL, Nathan PJ (2008) An examination of acute changes in serotonergic neurotransmission using the loudness dependence measure of auditory cortex evoked activity: effects of citalopram, escitalopram and sertraline. Hum Psychopharmacology 23(3):231-241 (Pubitemid 351577693)
33. Hariri AR, Holmes A (2006) Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 10(4):182-191
34. Harmer CJ, Bhagwagar Z, Perrett DI, Vollm BA, Cowen PJ, Goodwin GM (2003) Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 28 (1):148-152
35. Hegerl U, Juckel G (1993) Intensity dependence of auditory evoked potentials as an indicator of central serotonergic neurotransmission: a new hypothesis. Biol Psychiatry 33(3):173-187 (Pubitemid 23089966)
36. Hegerl U, Karnauchow I, Herrmann WM, Muller-Oerlinghausen B (1992) Intensity dependence of auditory evoked N1/P2 component and personality. Neuropsychobiology 26(3):166-172 (Pubitemid 23082062)
37. Hegerl U, Gallinat J, Mrowinski D (1994) Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 17 (1):1-13 (Pubitemid 24217848)
38. Hegerl U, Gallinat J, Mrowinski D (1995) Sensory cortical processing and the biological basis of personality. Biol Psychiatry 37 (7):467-472
39. Hegerl U, Gallinat J, Juckel G (2001) Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62 (1-2):93-100 (Pubitemid 32126614)
40. Huezo-Diaz P, Uher R, Smith R, Rietschel M, Henigsberg N, Marusic A et al (2009) Moderation of antidepressant response by the serotonin transporter gene. Br J Psychiatry 195(1):30-38
41. Hutchison KE, Stallings M, McGeary J, Bryan A (2004) Population stratification in the candidate gene study: fatal threat or red herring? Psychol Bull 130(1):66-79 (Pubitemid 38085392)
42. Hyttel J (1993) Comparative pharmacology of selective serotonin re-uptake inhibitors (SSRIs). Nord J Psychiatry 47(S30):5-12 (Pubitemid 23255957)
43. Hyttel J (1994) Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9 (Suppl 1):19-26 (Pubitemid 24107713)
44. Jensen JB, Jessop DS, Harbuz MS, Mork A, Sanchez C, Mikkelsen JD (1999) Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats. J Neuroendocrinol 11(6):465-471 (Pubitemid 29243770)
45. Jovanovic H, Karlsson P, Cerin A, Halldin C, Nordstrom AL (2009) 5- HT(1A) receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [(11)C] WAY100635 and [(11) C] MADAM PET. Psychiatry Res 172(1):31-37
46. Juckel G, Schmidt LG, Rommelspacher H, Hegerl U (1995) The Tridimensional Personality Questionnaire and the intensity dependence of auditory evoked dipole source activity. Biol Psychiatry 37(5):311-317
47. Juckel G, Csepe V, Molnar M, Hegerl U, Karmos G (1996) Intensity dependence of auditory evoked potentials in behaving cats. Electroencephalogr Clin Neurophysiol 100(6):527-537
48. Juckel G, Molnar M, Hegerl U, Csepe V, Karmos G (1997) Auditoryevoked potentials as indicator of brain serotonergic activity-first evidence in behaving cats. Biol Psychiatry 41(12):1181-1195 (Pubitemid 27237179)
49. Juckel G, Hegerl U, Molnar M, Csepe V, Karmos G (1999) Auditory evoked potentials reflect serotonergic neuronal activity-a study in behaving cats administered drugs acting on 5-HT1A autoreceptors in the dorsal raphe nucleus. Neuropsychopharmacology 21(6):710-716
50. Juckel G, Pogarell O, Augustin H, Mulert C, Muller-Siecheneder F, Frodl T et al (2007) Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder. J Clin Psychiatry 68(8):1206-1212 (Pubitemid 47395622)
51. Juckel G, Gudlowski Y, Muller D, Ozgurdal S, Brune M, Gallinat J et al (2008a) Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia-a replication study. Psychiatry Res 158 (1):79-82
52. Juckel G, Hegerl U, Giegling I, Mavrogiorgou P, Wutzler A, Schuhmacher C et al (2008b) Association of 5-HT1B receptor polymorphisms with the loudness dependence of auditory evoked potentials in a community-based sample of healthy volunteers. Am J Med Genet B Neuropsychiatr Genet 147B(4):454-458 (Pubitemid 351830802)
53. Juckel G, Kawohl W, Giegling I, Mavrogiorgou P, Winter C, Pogarell O et al (2008c) Association of catechol-O-methyltransferase variants with loudness dependence of auditory evoked potentials. Hum Psychopharmacol 23(2):115-120 (Pubitemid 351359583)
54. Juckel G, Schumacher C, Giegling I, Assion HJ, Mavrogiorgou P, Pogarell O et al (2010) Serotonergic functioning as measured by the loudness dependence of auditory evoked potentials is related to a haplotype in the brain-derived neurotrophic factor (BDNF) gene. J Psychiatr Res 44(8):541-546
55. Kahkonen S, Ahveninen J (2002) Combination of magneto- and electroencephalography in studies of monoamine modulation on attention. Methods Find Exp Clin Pharmacol 24(Suppl C):27-34 (Pubitemid 35447380)
56. Keers R, Uher R, Huezo-Diaz P, Smith R, Jaffee S, Rietschel M, et al. (2010) Interaction between serotonin transporter gene variants and life events predicts response to antidepressants in the GENDEP project. Pharmacogenomics J [Epub ahead of print]
57. Kikuchi H, Nakatani Y, Seki Y, Yu X, Sekiyama T, Sato-Suzuki I et al (2010) Decreased blood serotonin in the premenstrual phase enhances negative mood in healthy women. J Psychosom Obstet Gynaecol 31(2):83-89
58. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC et al (1998) Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 155 (3):373-379 (Pubitemid 28114895)
59. Lang UE, Hellweg R, Gallinat J (2005) Association of BDNF serum concentrations with central serotonergic activity: evidence from auditory signal processing. Neuropsychopharmacology 30 (6):1148-1153 (Pubitemid 40720973)
60. Massey AE, Marsh VR, McAllister-Williams RH (2004) Lack of effect of tryptophan depletion on the loudness dependency of auditory event related potentials in healthy volunteers. Biol Psychol 65(2):137-145 (Pubitemid 38050148)
61. McCloskey MS, Berman ME, Echevarria DJ, Coccaro EF (2009) Effects of acute alcohol intoxication and paroxetine on aggression in men. Alcohol Clin Exp Res 33(4):581-590
62. Miller GA, Gratton G, Yee CM (1988) Generalized implementation of an eye movement correction procedure. Psychophysiology 25 (2):241-243
63. Mombereau C, Gur TL, Onksen J, Blendy JA (2010) Differential effects of acute and repeated citalopram in mouse models of anxiety and depression. Int J Neuropsychopharmacol 13(3):321-334
64. Mulert C, Jäger L, Propp S, Karch S, Störmann S, Pogarell O et al (2005) Sound level dependence of the primary auditory cortex: simultaneous measurement with 61-channel EEG and fMRI. Neuroimage 28(1):49-58 (Pubitemid 41393887)
65. Mulert C, Juckel G, Brunnmeier M, Karch S, Leicht G, Mergl R et al (2007) Prediction of treatment response in major depression: integration of concepts. J Affect Disord 98(3):215-225 (Pubitemid 46149060)
66. Nathan PJ, Segrave R, Phan KL, O'Neill B, Croft RJ (2006) Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function. Hum Psychopharmacol 21(1):47-52 (Pubitemid 43192475)
67. Neumeister A, Konstantinidis A, Stastny J, Schwarz MJ, Vitouch O, Willeit M et al (2002) Association between serotonin transporter gene promoter polymorphism (5HTTLPR) and behavioral responses to tryptophan depletion in healthy women with and without family history of depression. Arch Gen Psychiatry 59 (7):613-620 (Pubitemid 34747241)
68. NHMRC (2007) National statement on ethical conduct in human research. National Health and Medical Research Council, Canberra
69. Norra C, Becker S, Brocheler A, Kawohl W, Kunert HJ, Buchner H (2008) Loudness dependence of evoked dipole source activity during acute serotonin challenge in females. Hum Psychopharmacol 23(1):31-42 (Pubitemid 351166066)
70. O'Neill BV, Croft RJ, Leung S, Guille V, Galloway M, Phan KL et al (2006) Dopamine receptor stimulation does not modulate the loudness dependence of the auditory evoked potential in humans. Psychopharmacology (Berl) 188(1):92-99 (Pubitemid 44268245)
71. O'Neill BV, Croft RJ, Leung S, Oliver C, Phan KL, Nathan PJ (2007) High-dose glycine inhibits the loudness dependence of the auditory evoked potential (LDAEP) in healthy humans. Psychopharmacology (Berl) 195(1):85-93 (Pubitemid 47568619)
72. O'Neill BV, Croft RJ, Nathan PJ (2008a) The loudness dependence of the auditory evoked potential (LDAEP) as an in vivo biomarker of central serotonergic function in humans: rationale, evaluation and review of findings. Hum Psychopharmacol 23(5):355-370
73. O'Neill BV, Guille V, Croft RJ, Leung S, Scholes KE, Phan KL et al (2008b) Effects of selective and combined serotonin and dopamine depletion on the loudness dependence of the auditory evoked potential (LDAEP) in humans. Hum Psychopharmacol 23 (4):301-312 (Pubitemid 351982667)
74. Owens MJ, Knight DL, Nemeroff CB (2001) Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine. Biol Psychiatry 50(5):345-350 (Pubitemid 32816947)
75. Park YM, Lee SH, Kim S, Bae SM (2010) The loudness dependence of the auditory evoked potential (LDAEP) in schizophrenia, bipolar disorder, major depressive disorder, anxiety disorder, and healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 34 (2):313-316
76. Pogarell O, Tatsch K, Juckel G, Hamann C, Mulert C, Popperl G et al (2004) Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder. Neuropsychopharmacology 29(10):1910-1917 (Pubitemid 39336802)
77. Preskorn SH (1996) Clinical pharmacology of SSRI's (first ed.). Professional Communications, Caddo
78. Puerta E, Hervias I, Aguirre N (2009) On the mechanisms underlying 3,4-methylenedioxymethamphetamine toxicity: the dilemma of the chicken and the egg. Neuropsychobiology 60(3-4):119-129
79. Riedel WJ, Eikmans K, Heldens A, Schmitt JA (2005) Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment. J Psychopharmacol 19 (1):12-20
80. Ronfeld RA, Wilner KD, Baris BA (1997) Sertraline. Chronopharmacokinetics and the effect of coadministration with food. Clin Pharmacokinet 32(Suppl 1):50-55 (Pubitemid 27107720)
81. Schmitt JA, Ramaekers JG, Kruizinga MJ, van Boxtel MP, Vuurman EF, Riedel WJ (2002) Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man. J Psychopharmacol 16(3):207-214 (Pubitemid 34983074)
82. Segrave R, Croft RJ, Illic S, Luan Phan K, Nathan PJ (2006) Pindolol does not augment central serotonin function increases to citalopram in humans: an auditory evoked potential investigation. Pharmacol Biochem Behav 85(1):82-90 (Pubitemid 44772912)
83. Senkowski D, Linden M, Zubragel D, Bar T, Gallinat J (2003) Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder. Biol Psychiatry 53(4):304-314 (Pubitemid 36175544)
84. Simmons JG, Allen NB, Judd FK, Norman TR (2000) Serotonin and emotion: a psychophysiological evaluation. Psychophysiology 37:S90
85. Smeraldi E, Zanardi R, Benedetti F, Di Bella D, Perez J, Catalano M (1998) Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine. Mol Psychiatry 3(6):508-511 (Pubitemid 28515526)
86. Tse WS, Bond AJ (2001) Serotonergic involvement in the psychosocial dimension of personality. J Psychopharmacology 15(3):195-198 (Pubitemid 32808254)
87. Tse WS, Bond AJ (2002) Difference in serotonergic and noradrenergic regulation of human social behaviours. Psychopharmacology (Berlin) 159(2):216-221 (Pubitemid 34146567)
88. Tuchtenhagen F, Daumann J, Norra C, Gobbele R, Becker S, Pelz S et al (2000) High intensity dependence of auditory evoked dipole source activity indicates decreased serotonergic activity in abstinent ecstasy (MDMA) users. Neuropsychopharmacology 22(6):608-617 (Pubitemid 30219404)
89. Uhl I, Gorynia I, Gallinat J, Mulert C, Wutzler A, Heinz A et al (2006) Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol 21(7):463-471 (Pubitemid 44660186)
90. Vaughan HG Jr, Ritter W (1970) The sources of auditory evoked responses recorded from the human scalp. Electroencephalogr Clin Neurophysiol 28(4):360-367
91. Watson D, Clark L, Tellegen A (1988) Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol 54:1063-1070
92. Wutzler A, Winter C, Kitzrow W, Uhl I, Wolf RJ, Heinz A et al (2008) Loudness dependence of auditory evoked potentials as indicator of central serotonergic neurotransmission: simultaneous electrophysiological recordings and in vivo microdialysis in the rat primary auditory cortex. Neuropsychopharmacology 33 (13):3176-3181